Virtu KCG Holdings’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Virtu KCG Holdings’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-18,205	Closed	-$409K	–	4000
2016 Q4	$409K	Buy	+18,205	New	+$356K	0.01%	1745
2016 Q1	–	Sell	-10,663	Closed	-$549K	–	3942
2015 Q4	$549K	Buy	10,663 +384	+4%	+$18.6K	0.01%	1431
2015 Q3	$438K	Buy	+10,279	New	+$496K	0.01%	1670
2014 Q4	–	Sell	-9,258	Closed	-$234K	–	4392
2014 Q3	$234K	Buy	+9,258	New	+$244K	﹤0.01%	2708

Other funds holding PTLA

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Virtu KCG Holdings's PTLA Position: Q1 2017 in Review

Virtu KCG Holdings sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2017, closing a stake of 18,205 shares — an estimated $409K sold.

Virtu KCG Holdings first reported a position in PTLA in Q3 2014 and held it in 4 quarters. The position peaked at $549K in Q4 2015. 180 funds tracked by Wall St. Rank hold PTLA as of Q1 2017.

Virtu KCG Holdings reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
Virtu KCG Holdings sold 18,205 Portola Pharmaceuticals, Inc. shares in Q1 2017, an estimated $409K.
Virtu KCG Holdings first reported a position in Portola Pharmaceuticals, Inc. in Q3 2014 and held it in 4 quarters.
Virtu KCG Holdings's Portola Pharmaceuticals, Inc. position peaked at $549K in Q4 2015.
180 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2017.

Based on Virtu KCG Holdings's 13F filing for Q1 2017, filed 12 May 2017.